<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">FASEB J</journal-id>
<journal-id journal-id-type="iso-abbrev">FASEB J</journal-id>
<journal-id journal-id-type="hwp">fasebj</journal-id>
<journal-id journal-id-type="pmc">fasebj</journal-id>
<journal-id journal-id-type="publisher-id">FASEB</journal-id>
<journal-title-group>
<journal-title>The FASEB Journal</journal-title>
</journal-title-group>
<issn pub-type="ppub">0892-6638</issn>
<issn pub-type="epub">1530-6860</issn>
<publisher>
<publisher-name>Federation of American Societies for Experimental Biology</publisher-name>
<publisher-loc>Bethesda, MD, USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27864377</article-id>
<article-id pub-id-type="pmc">5354548</article-id>
<article-id pub-id-type="publisher-id">FJ_201601004R</article-id>
<article-id pub-id-type="doi">10.1096/fj.201601004R</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Mitochondrial and redox abnormalities in autism lymphoblastoid cells: a sibling control study</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Rose</surname>
<given-names>Shannon</given-names>
</name>
<xref ref-type="aff" rid="aff1">*</xref>
<xref ref-type="aff" rid="aff2">
<sup>†</sup>
</xref>
<xref ref-type="corresp" rid="cor1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bennuri</surname>
<given-names>Sirish C.</given-names>
</name>
<xref ref-type="aff" rid="aff1">*</xref>
<xref ref-type="aff" rid="aff2">
<sup>†</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wynne</surname>
<given-names>Rebecca</given-names>
</name>
<xref ref-type="aff" rid="aff1">*</xref>
<xref ref-type="aff" rid="aff2">
<sup>†</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Melnyk</surname>
<given-names>Stepan</given-names>
</name>
<xref ref-type="aff" rid="aff1">*</xref>
<xref ref-type="aff" rid="aff2">
<sup>†</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>James</surname>
<given-names>S. Jill</given-names>
</name>
<xref ref-type="aff" rid="aff1">*</xref>
<xref ref-type="aff" rid="aff2">
<sup>†</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Frye</surname>
<given-names>Richard E.</given-names>
</name>
<xref ref-type="aff" rid="aff1">*</xref>
<xref ref-type="aff" rid="aff2">
<sup>†</sup>
</xref>
</contrib>
<aff id="aff1"><label>*</label>Arkansas Children’s Research Institute, Little Rock, Arkansas, USA; and</aff>
<aff id="aff2"><label>†</label>Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA</aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>1</label>Correspondence: <addr-line>Arkansas Children’s Research Institute, 13 Children’s Way, Slot 512-41B, Little Rock, Arkansas 72202, USA.</addr-line> E-mail: <email>srose@uams.edu</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>3</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>18</day>
<month>11</month>
<year>2016</year>
</pub-date>
<volume>31</volume>
<issue>3</issue>
<fpage>904</fpage>
<lpage>909</lpage>
<history>
<date date-type="received">
<day>31</day>
<month>8</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>07</day>
<month>11</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s)</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>FASEB</copyright-holder>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International (CC BY 4.0) (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<self-uri xlink:href="fasebj201601004R.pdf" xlink:title="pdf"></self-uri>
<abstract>
<p>Autism spectrum disorder (ASD) is associated with physiological abnormalities, including abnormal redox and mitochondrial metabolism. Lymphoblastoid cell lines (LCLs) from some children with ASD exhibit increased oxidative stress, decreased glutathione redox capacity, and highly active mitochondria with increased vulnerability to reactive oxygen species (ROS). Because unaffected siblings (Sibs) of individuals with ASD share some redox abnormalities, we sought to determine whether LCLs from Sibs share ASD-associated mitochondrial abnormalities. We evaluated mitochondrial bioenergetics in 10 sets of LCLs from children with ASD, Sibs, and unrelated/unaffected controls (Cons) after acute increases in ROS. Additionally, intracellular glutathione and uncoupling protein 2 (<italic>UCP2</italic>) gene expressions were quantified. Compared to Sib LCLs, ASD LCLs exhibited significantly higher ATP-linked respiration, higher maximal and reserve respiratory capacity, and greater glycolysis and glycolytic reserve. ASD LCLs exhibited a significantly greater change in these parameters, with acute increases in ROS compared to both Sib and Con LCLs. Compared to Con, both ASD and Sib LCLs exhibited significantly higher proton leak respiration. Consistent with this, intracellular glutathione redox capacity was decreased and <italic>UCP2</italic> gene expression was increased in both ASD and Sib compared to Con LCLs. These data indicate that mitochondrial respiratory function, not abnormal redox homeostasis, distinguishes ASD from unaffected LCLs.—Rose, S., Bennuri, S. C., Wynne, R., Melnyk, S., James, S. J., Frye, R. E. Mitochondrial and redox abnormalities in autism lymphoblastoid cells: a sibling control study.</p>
</abstract>
<kwd-group>
<kwd>autistic disorder</kwd>
<kwd>bioenergetics</kwd>
<kwd>glutathione</kwd>
<kwd>oxidative stress</kwd>
<kwd>UCP2</kwd>
</kwd-group>
<counts>
<fig-count count="5"></fig-count>
<table-count count="1"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="24"></ref-count>
<page-count count="6"></page-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name> DJS Export </meta-name>
<meta-value>v1</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<p>There is an increased recognition that several physiological abnormalities are related to autism (<xref ref-type="bibr" rid="B1">1</xref>), including mitochondrial dysfunction (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B3">3</xref>). Some studies estimate that 50% or more of children with autism manifest biomarkers of mitochondrial dysfunction (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B5">5</xref>), while other studies have suggested that 80% of children with autism have abnormal electron transport chain function (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7</xref>). We recently demonstrated a novel type of mitochondrial dysfunction in approximately one-third of lymphoblastoid cell lines (LCLs) from children with autism spectrum disorder (ASD) compared to LCLs from unaffected controls (Cons). This subgroup of ASD LCLs exhibited increases in respiratory activity, vulnerability to reactive oxygen species (ROS), and uncoupling protein 2 (UCP2) content (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B9">9</xref>). It is unclear whether mitochondrial dysfunction is driven by other metabolic abnormalities associated with ASD, such as oxidative stress, or whether it is specifically linked to ASD. Unaffected siblings (Sibs) of ASD individuals also demonstrate some redox abnormalities (<xref ref-type="bibr" rid="B10">10</xref>). Whether Sibs also exhibit mitochondrial abnormalities is unknown.</p>
<p>To determine the role of redox abnormalities in mitochondrial dysfunction associated with ASD and whether a particular metabolic abnormality is specific for ASD, we compared mitochondrial respiration with and without ROS exposure as well as intracellular glutathione content and <italic>UCP2</italic> gene expression in LCLs from children with ASD, Sibs, and unrelated Cons.</p>
<sec id="s1" sec-type="materials|methods">
<title>MATERIALS AND METHODS</title>
<sec id="s2">
<title>Materials</title>
<p>RPMI 1640 culture medium, penicillin/streptomycin, fetal bovine serum, PBS, and BCA Protein Assay Kit were all obtained from Thermo Fisher Scientific (Waltham, MA, USA). XF DMEM and XF-PS 96-well plates were obtained from Agilent Technologies (Santa Clara, CA, USA). The RNeasy Mini Kit was obtained from Qiagen (Germantown, MD, USA) and the High Capacity cDNA Reverse Transcription Kit and Power SYBR Green PCR Master Mix from Thermo Fisher Scientific. Poly-<sc>d</sc>-lysine, 2,3-dimethoxy-1,4-napthoquinone (DMNQ), meta-phosphoric acid, and all other chemicals were obtained from Sigma-Aldrich (St. Louis, MO, USA).</p>
</sec>
<sec id="s3">
<title>Cell lines and culture</title>
<p>Ten pairs of LCLs derived from multiplex families with 1 male member diagnosed with ASD and 1 unaffected male Sib were obtained from the Autism Genetic Resource Exchange (Los Angeles, CA, USA). Seven unrelated age-matched Con LCLs derived from healthy male donors with no documented behavioral or neurological disorder or first-degree relative with a medical disorder that could involve abnormal mitochondrial function were obtained from Coriell Cell Repository (Camden, NJ, USA). Details of the LCLs are presented in <xref ref-type="table" rid="T1"><bold>Table 1</bold></xref>. Seven of the ASD LCLs examined here were previously included as part of a larger cohort that we classified according to mitochondrial phenotype and reported an atypical mitochondrial phenotype in approximately 30% of the ASD LCLs (<xref ref-type="bibr" rid="B9">9</xref>). In that study, 3 were characterized as atypical and 4 were characterized as typical, and 3 have not been previously studied. LCLs were maintained in RPMI 1640 culture medium with 15% fetal bovine serum and 1% penicillin/streptomycin in a humidified incubator at 37°C with 5% CO<sub>2</sub>. All ASD LCLs were linked to the results of the reference-standard Autism Diagnostic Observation Schedule (ADOS) assessments of the children from which the LCLs were derived.</p>
<table-wrap id="T1" orientation="portrait" position="float">
<label>TABLE 1</label>
<caption>
<p>Matched LCLs</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" colspan="2" rowspan="1" valign="top">Unrelated/unaffected Con</th>
<th align="center" colspan="2" rowspan="1" valign="top">ASD</th>
<th align="center" colspan="2" rowspan="1" valign="top">Unaffected Sib</th>
</tr>
<tr>
<th colspan="1" rowspan="1" valign="top">LCL</th>
<th align="center" colspan="1" rowspan="1" valign="top">Age</th>
<th align="center" colspan="1" rowspan="1" valign="top">LCL</th>
<th align="center" colspan="1" rowspan="1" valign="top">Age</th>
<th align="center" colspan="1" rowspan="1" valign="top">LCL</th>
<th align="center" colspan="1" rowspan="1" valign="top">Age</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="1" rowspan="1" valign="top">GM09659</td>
<td align="center" colspan="1" rowspan="1" valign="top">4</td>
<td align="center" colspan="1" rowspan="1" valign="top">AU1393306</td>
<td align="center" colspan="1" rowspan="1" valign="top">3</td>
<td align="center" colspan="1" rowspan="1" valign="top">AU1393305</td>
<td align="center" colspan="1" rowspan="1" valign="top">4</td>
</tr>
<tr>
<td colspan="1" rowspan="1" valign="top">GM11599</td>
<td align="center" colspan="1" rowspan="1" valign="top">9</td>
<td align="center" colspan="1" rowspan="1" valign="top">AU038804</td>
<td align="center" colspan="1" rowspan="1" valign="top">8</td>
<td align="center" colspan="1" rowspan="1" valign="top">AU038803</td>
<td align="center" colspan="1" rowspan="1" valign="top">9</td>
</tr>
<tr>
<td colspan="1" rowspan="1" valign="top">GM15862</td>
<td align="center" colspan="1" rowspan="1" valign="top">11</td>
<td align="center" colspan="1" rowspan="1" valign="top">AU0939303</td>
<td align="center" colspan="1" rowspan="1" valign="top">11</td>
<td align="center" colspan="1" rowspan="1" valign="top">AU0939302</td>
<td align="center" colspan="1" rowspan="1" valign="top">8</td>
</tr>
<tr>
<td colspan="1" rowspan="1" valign="top">GM10153</td>
<td align="center" colspan="1" rowspan="1" valign="top">10</td>
<td align="center" colspan="1" rowspan="1" valign="top">AU1267302</td>
<td align="center" colspan="1" rowspan="1" valign="top">10</td>
<td align="center" colspan="1" rowspan="1" valign="top">AU1267303</td>
<td align="center" colspan="1" rowspan="1" valign="top">7</td>
</tr>
<tr>
<td colspan="1" rowspan="1" valign="top">GM16007</td>
<td align="center" colspan="1" rowspan="1" valign="top">12</td>
<td align="center" colspan="1" rowspan="1" valign="top">AU1348303</td>
<td align="center" colspan="1" rowspan="1" valign="top">12</td>
<td align="center" colspan="1" rowspan="1" valign="top">AU1348302</td>
<td align="center" colspan="1" rowspan="1" valign="top">13</td>
</tr>
<tr>
<td colspan="1" rowspan="1" valign="top">GM09621</td>
<td align="center" colspan="1" rowspan="1" valign="top">8</td>
<td align="center" colspan="1" rowspan="1" valign="top">AU1344302</td>
<td align="center" colspan="1" rowspan="1" valign="top">7</td>
<td align="center" colspan="1" rowspan="1" valign="top">AU1344303</td>
<td align="center" colspan="1" rowspan="1" valign="top">4</td>
</tr>
<tr>
<td colspan="1" rowspan="1" valign="top">GM09621</td>
<td align="center" colspan="1" rowspan="1" valign="top">8</td>
<td align="center" colspan="1" rowspan="1" valign="top">AU1280302</td>
<td align="center" colspan="1" rowspan="1" valign="top">7</td>
<td align="center" colspan="1" rowspan="1" valign="top">AU1280304</td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
</tr>
<tr>
<td colspan="1" rowspan="1" valign="top">GM16007</td>
<td align="center" colspan="1" rowspan="1" valign="top">12</td>
<td align="center" colspan="1" rowspan="1" valign="top">AU1215301</td>
<td align="center" colspan="1" rowspan="1" valign="top">12</td>
<td align="center" colspan="1" rowspan="1" valign="top">AU1215305</td>
<td align="center" colspan="1" rowspan="1" valign="top">2</td>
</tr>
<tr>
<td colspan="1" rowspan="1" valign="top">GM11626</td>
<td align="center" colspan="1" rowspan="1" valign="top">13</td>
<td align="center" colspan="1" rowspan="1" valign="top">AU008404</td>
<td align="center" colspan="1" rowspan="1" valign="top">13</td>
<td align="center" colspan="1" rowspan="1" valign="top">AU008405</td>
<td align="center" colspan="1" rowspan="1" valign="top">9</td>
</tr>
<tr>
<td colspan="1" rowspan="1" valign="top">GM11626</td>
<td align="center" colspan="1" rowspan="1" valign="top">13</td>
<td align="center" colspan="1" rowspan="1" valign="top">AU1165302</td>
<td align="center" colspan="1" rowspan="1" valign="top">13</td>
<td align="center" colspan="1" rowspan="1" valign="top">AU1165303</td>
<td align="center" colspan="1" rowspan="1" valign="top">12</td>
</tr>
<tr>
<td colspan="1" rowspan="1" valign="top">Mean ± <sc>se</sc>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">10 ± 0.9</td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" valign="top">9.6 ± 1.1</td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" valign="top">6.9 ± 1.4</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s4">
<title>Mitochondrial respiration</title>
<p>Mitochondrial oxygen consumption rate and extracellular acidification rate (ECAR) were measured in real time in live intact LCLs using a Seahorse Extracellular Flux (XF) 96 Analyzer (Agilent Technologies) with details previously published (<xref ref-type="bibr" rid="B9">9</xref>). Briefly, age- and gender-matched sets of LCLs consisting of ASD, Sib, and Con LCLs were seeded onto poly-<sc>d</sc>-lysine-coated 96-well XF-PS plates in XF DMEM with at least 3 replicate wells per treatment group. The cells were then treated for 1 h with the redox cycling agent DMNQ, which enters cells and generates both superoxide and hydrogen peroxide similar to levels generated by NADPH oxidase (<xref ref-type="bibr" rid="B11">11</xref>). DMNQ (5 mg/ml) was prepared in DMSO and diluted in XF DMEM into 10× stocks and added directly into wells of the XF plate incubated for 1 h at 37°C in a non-CO<sub>2</sub> incubator with final concentrations of 5, 10, and 15 μM DMNQ. Previously, we demonstrated that these concentrations of DMNQ increase oxidative stress in LCLs (<xref ref-type="bibr" rid="B9">9</xref>).</p>
</sec>
<sec id="s5">
<title>Quantification of intracellular glutathione</title>
<p>Intracellular free reduced glutathione (GSH) and oxidized glutathione (GSSG) were quantified in each of the 27 cell lines by HPLC as previously described (<xref ref-type="bibr" rid="B12">12</xref>). Briefly, approximately 5 million untreated cells from each cell line were pelleted and snap-frozen on dry ice and stored at −80°C. Upon thawing, cells were lysed by sonication in ice-cold PBS, followed by the addition of ice-cold 10% meta-phosphoric acid. After a 30-min incubation on ice, samples were centrifuged for 15 min at 18,000 <italic>g</italic> at 4°C. Results are expressed per protein using the BCA Protein Assay Kit.</p>
</sec>
<sec id="s6">
<title><italic>UCP2</italic> gene expression</title>
<p>Total RNA was isolated from 5 million untreated cells from each of the 27 cell lines using the RNeasy Mini Kit following the manufacturer’s protocol. cDNA synthesis (2 µg per 20 µl reaction mix) was performed using the High Capacity cDNA Reverse Transcription Kit as indicated by the manufacturer. Quantitative PCR reactions were performed using Power SYBR Green PCR Master Mix on an ABI 7900HT Fast Real-Time PCR system (Thermo Fisher Scientific). Relative quantification was performed to the housekeeping gene hypoxanthine phosphoribosyltransferase 1 (<italic>HPRT1</italic>). Primers for <italic>UCP2</italic> (F: 5′–TCCTGAAAGCCAACCTCATG–3′; R: 5′–GGCAGAGTTCATGTATCTCGTC–3′) and <italic>HPRT1</italic> (F: 5′–TGCTGAGGATTTGGAAAGGG–3′; R: 5′–ACAGAGGGCTACAATGTGATG–3′) were designed using the real-time PCR tool from IDT DNA (<italic><ext-link ext-link-type="uri" xlink:href="http://www.idtdna.com/">http://www.idtdna.com/</ext-link></italic>).</p>
</sec>
<sec id="s7">
<title>Statistical analyses</title>
<p>Respiratory parameters were analyzed using mixed-model regression (SAS 9.3; SAS Institute, Cary, NC, USA), similar to our previous studies (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B9">9</xref>). Respiratory parameters from ASD LCLs were compared to paired Sib and Con LCLs with group as the between-group effect and DMNQ as the within-group repeated factor. DMNQ was modeled to the second power to account for the curvilinear relationship. Presented are the overall differences between the groups (group effect), the linear and quadratic effects of DMNQ, and interaction between the group and the linear and quadratic effect of DMNQ. For all models, random effects included the intercept and DMNQ. Significance was evaluated with <italic>F</italic> tests. Planned <italic>post hoc</italic> orthogonal contrasts were used when the interaction was significant. We also investigated whether ASD symptoms were linked to changes in oxygen consumption rate and ECAR parameters only in the ASD LCLs. In these analyses, we examined the ADOS scores of Total Communication and Social Symptoms and Total Stereotyped Behaviors and Restricted Interests (SBRI) separately. The change in overall parameters as well as the interaction with the linear effect of DMNQ were investigated. Differences between glutathione content and <italic>UCP2</italic> expression across groups were performed similar to the analyses previously described.</p>
</sec>
</sec>
<sec id="s8" sec-type="results">
<title>RESULTS</title>
<sec id="s9">
<title>Oxygen consumption</title>
<p>Overall ATP-linked respiration, maximal respiratory capacity, and reserve capacity were significantly greater in ASD compared to both Sib and Con LCLs (<italic>P</italic> &lt; 0.005 for all). At baseline (0 DMNQ), ATP-linked respiration was 35 and 32% higher in ASD LCLs compared to Sib and Con LCLs, respectively (<xref ref-type="fig" rid="F1"><bold>Fig. 1<italic>A</italic></bold></xref>). While ASD and Sib LCLs are discordant for abnormalities in mitochondrial respiratory parameters linked to ATP production, they exhibited similar proton leak respiration (<xref ref-type="fig" rid="F1">Fig. 1<italic>B</italic></xref>). Maximal respiratory capacity at baseline was approximately 48% higher in ASD than both Sib and Con LCLs (<xref ref-type="fig" rid="F1">Fig. 1<italic>C</italic></xref>). Mitochondrial reserve capacity at baseline was 60% higher in ASD than Sib and 52% higher than Con LCLs (<xref ref-type="fig" rid="F1">Fig. 1<italic>D</italic></xref>). The increase in ATP-linked respiration and the decrease in reserve capacity with increased ROS were greater in ASD than in Sib and Con LCLs (<italic>P</italic> &lt; 0.05 for all). Compared to Con LCLs, baseline proton leak respiration was elevated 93% in ASD and 57% in Sib LCLs, and proton leak respiration was significantly higher overall in ASD and Sib compared to Con LCLs (<italic>P</italic> &lt; 0.005 for all).</p>
<fig fig-type="figure" id="F1" orientation="portrait" position="float">
<label>Figure 1.</label>
<caption>
<p>Mitochondrial respiratory parameters. Mean curves of mitochondrial parameters with 1 h exposure to DMNQ are outlined by upper and lower standard errors. <italic>A</italic>) Both overall [<italic>F</italic>(2,423) = 7.60, <italic>P</italic> &lt; 0.001] and change in ATP-linked respiration [<italic>F</italic>(2,423) = 3.64, <italic>P</italic> &lt; 0.05] differed across groups, with ASD LCLs exhibiting markedly higher overall ATP-linked respiration compared to Sib [<italic>t</italic>(423) = 3.61, <italic>P</italic> &lt; 0.001] and Con [<italic>t</italic>(423) = 3.03, <italic>P</italic> &lt; 0.005] LCLs and greater change in ATP-linked respiration with DMNQ compared to Sib [<italic>t</italic>(423) = 2.03, <italic>P</italic> &lt; 0.05] and Con [<italic>t</italic>(405) = 2.55, <italic>P</italic> = 0.01] LCLs. <italic>B</italic>) Overall proton leak [<italic>F</italic>(2,423) = 12.07, <italic>P</italic> &lt; 0.0001] differed across groups, with lower overall proton leak in Con compared to ASD [<italic>t</italic>(423) = 4.86, <italic>P</italic> &lt; 0.0001] and Sib [<italic>t</italic>(423) = −3.19, <italic>P</italic> &lt; 0.005] LCLs. <italic>C</italic>) Overall maximal respiratory capacity differed across groups [<italic>F</italic>(2,423) = 25.34, <italic>P</italic> &lt; 0.0001], with higher maximal respiratory capacity in ASD compared to Sib [<italic>t</italic>(423) = 6.26, <italic>P</italic> &lt; 0.001] and Con [<italic>t</italic>(423) = 5.97, <italic>P</italic> &lt; 0.001] LCLs. <italic>D</italic>) Both overall [<italic>F</italic>(2,423) = 20.77, <italic>P</italic> &lt; 0.001] and change in reserve capacity with DMNQ [<italic>F</italic>(2,423) = 5.67, <italic>P</italic> &lt; 0.005] differed across groups. Reserve capacity was markedly higher in ASD compared to Sib [<italic>t</italic>(423) = 6.01, <italic>P</italic> &lt; 0.0001] and Con [<italic>t</italic>(423) = 4.93, <italic>P</italic> &lt; 0.001] LCLs, and decrease in reserve capacity with DMNQ was greater in ASD compared to Sib [<italic>t</italic>(423) = 3.10, <italic>P</italic> &lt; 0.005] and Con [<italic>t</italic>(405) = 2.67, <italic>P</italic> &lt; 0.01] LCLs.</p>
</caption>
<graphic xlink:href="fasebj201601004Rf1"></graphic>
</fig>
</sec>
<sec id="s10">
<title>Glycolysis</title>
<p>Glycolytic parameters were assessed during the same assay using the ECAR and are presented in <xref ref-type="fig" rid="F2"><bold>Fig. 2</bold></xref>. Overall, both basal glycolysis and glycolytic reserve were significantly elevated in ASD compared to Sib and Con LCLs (<italic>P</italic> &lt; 0.05 for all). At baseline (0 DMNQ), basal glycolysis was 19 and 12% higher in ASD compared to Sib and Con LCLs, respectively (<xref ref-type="fig" rid="F2">Fig. 2<italic>A</italic></xref>). Glycolytic reserve at baseline was approximately 89 and 56% higher in ASD than Sib and Con LCLs, respectively (<xref ref-type="fig" rid="F2">Fig. 2<italic>B</italic></xref>). The decrease in basal glycolysis with DMNQ was greater in ASD than in Sib and Con LCLs (<italic>P</italic> ≤ 0.005 for all).</p>
<fig fig-type="figure" id="F2" orientation="portrait" position="float">
<label>Figure 2.</label>
<caption>
<p>Glycolytic parameters. Mean curves of glycolytic parameters with 1 h exposure to DMNQ are outlined by upper and lower standard errors. <italic>A</italic>) Both overall [<italic>F</italic>(2,370) = 5.34, <italic>P</italic> &lt; 0.01] and change in glycolysis [<italic>F</italic>(2,370) = 5.77, <italic>P</italic> &lt; 0.005] differed across groups. Overall glycolysis was markedly higher in ASD compared to Sib [<italic>t</italic>(370) = 2.57, <italic>P</italic> = 0.01] and Con [<italic>t</italic>(370) = 3.03, <italic>P</italic> &lt; 0.005] LCLs, and decrease in glycolysis with DMNQ was significantly greater in ASD compared to Sib [<italic>t</italic>(370) = 2.96, <italic>P</italic> &lt; 0.005] and Con [<italic>t</italic>(370) = 2.95, <italic>P</italic> = 0.005] LCLs. <italic>B</italic>) LCL groups differed in overall glycolytic reserve [<italic>F</italic>(2,370) = 4.15, <italic>P</italic> &lt; 0.05]. Glycolytic reserve was markedly higher in ASD compared to Sib [<italic>t</italic>(370) = 2.28, <italic>P</italic> &lt; 0.05] and Con [<italic>t</italic>(370) = 2.66, <italic>P</italic> &lt; 0.05] LCLs.</p>
</caption>
<graphic xlink:href="fasebj201601004Rf2"></graphic>
</fig>
</sec>
<sec id="s11">
<title>Correlations with SBRI scores</title>
<p>The effect of DMNQ on ATP-Linked respiration was dependent on SBRI score. <xref ref-type="fig" rid="F3"><bold>Figure 3<italic>A</italic></bold></xref> demonstrates that those with higher SBRI scores (<italic>i.e.,</italic> more behaviors; red lines) started out with a higher ATP-linked respiration and had a more significant drop in ATP-linked respiration than individuals with relatively more mild repetitive behaviors (green lines). The SBRI score was also significantly associated with overall glycolytic reserve (<italic>P</italic> &lt; 0.05) such that more severe scores were related to a higher glycolytic reserve (<xref ref-type="fig" rid="F3">Fig. 3<italic>B</italic></xref>). No other associations between ADOS scores and any other end points were found.</p>
<fig fig-type="figure" id="F3" orientation="portrait" position="float">
<label>Figure 3.</label>
<caption>
<p>SBRI total scores correlate with bioenergetics. <italic>A</italic>) Effect of DMNQ on ATP-linked respiration was dependent on SBRI total score [<italic>F</italic>(1,131) = 6.60,<italic>P</italic> = 0.01]. Mean curves of ATP-linked respiration with 1 h exposure to DMNQ are outlined by upper and lower standard errors. Those with more severe stereotyped and repetitive behaviors (red lines) started out with higher ATP-linked respiration and had greater drop in ATP-linked respiration than individuals with relatively more mild repetitive behaviors (green lines). <italic>B</italic>) SBRI total score was related to overall glycolytic reserve [<italic>F</italic>(1,125) = 5.60,<italic>P</italic> &lt; 0.05] such that more severe scores were related to higher glycolytic reserve.</p>
</caption>
<graphic xlink:href="fasebj201601004Rf3"></graphic>
</fig>
</sec>
<sec id="s12">
<title>Intracellular glutathione</title>
<p>The glutathione thiol/disulfide redox buffer (GSH/GSSG) is the major mechanism responsible for maintaining a reduced intracellular microenvironment. Intracellular free GSH and GSSG were quantified by HPLC. ASD LCLs exhibited 14% less intracellular GSH compared to Sib (<italic>P</italic> &lt; 0.05) and 19% less GSH compared to Con LCLs (<italic>P</italic> &lt; 0.001; <xref ref-type="fig" rid="F4"><bold>Fig. 4<italic>A</italic></bold></xref>). Oxidized GSSG was 15% higher in Sib compared to Con LCLs (<italic>P</italic> &lt; 0.005; <xref ref-type="fig" rid="F4">Fig. 4<italic>B</italic></xref>). The glutathione redox ratio (GSH/GSSG) was decreased by 22% in ASD (<italic>P</italic> &lt; 0.001) and 18% in Sib (<italic>P</italic> &lt; 0.01) compared to Con LCLs (<xref ref-type="fig" rid="F4">Fig. 4<italic>C</italic></xref>).</p>
<fig fig-type="figure" id="F4" orientation="portrait" position="float">
<label>Figure 4.</label>
<caption>
<p>Intracellular glutathione parameters. <italic>A</italic>) GSH differed across groups [<italic>F</italic>(2,18) = 8.95, <italic>P</italic> &lt; 0.01] as ASD LCLs exhibited lower GSH compared to Sib [<italic>t</italic>(18) = 2.46, <italic>P</italic> &lt; 0.05] and Con [<italic>t</italic>(18) = 4.21, <italic>P</italic> &lt; 0.001] LCLs. <italic>B</italic>) GSSG differed across groups [<italic>F</italic>(2,18) = 2.27, <italic>P</italic> = 0.05] as Sib LCLs exhibited greater GSSG than Con [<italic>t</italic>(18) = 2.45, <italic>P</italic> &lt; 0.05] LCLs. <italic>C</italic>) GSH/GSSG differed across groups [<italic>F</italic>(2,18) = 10.57, <italic>P</italic> &lt; 0.001] due to lower GSH/GSSG in ASD [<italic>t</italic>(18) = 4.27, <italic>P</italic> &lt; 0.001] and Sib [<italic>t</italic>(18) = 3.61, <italic>P</italic> &lt; 0.01] LCLs compared to Con LCLs. *<italic>P</italic> &lt; 0.001, **<italic>P</italic> &lt; 0.01; <sup>ŧ</sup><italic>P</italic> &lt; 0.05.</p>
</caption>
<graphic xlink:href="fasebj201601004Rf4"></graphic>
</fig>
</sec>
<sec id="s13">
<title>Gene expression</title>
<p><italic>UCP2,</italic> a major regulatory mechanism responsible for reducing ROS at the inner mitochondrial membrane, is known to be up-regulated in response to mitochondrial oxidative stress to relieve the proton gradient across the inner mitochondrial membrane (<xref ref-type="bibr" rid="B13">13</xref><xref ref-type="bibr" rid="B14"></xref>–<xref ref-type="bibr" rid="B15">15</xref>). <italic>UCP2</italic> gene expression was examined by quantitative PCR and was found to be elevated by 38% in ASD (<italic>P</italic> &lt; 0.05) and 57% in Sib LCLs (<italic>P</italic> &lt; 0.001) compared to Con LCLs (<xref ref-type="fig" rid="F5"><bold>Fig. 5</bold></xref>).</p>
<fig fig-type="figure" id="F5" orientation="portrait" position="float">
<label>Figure 5.</label>
<caption>
<p><italic>UCP2</italic> gene expression normalized to housekeeping gene <italic>HPRT1.</italic>
<italic>UCP2</italic> expression was significantly different across groups [<italic>F</italic>(2,36) = 7.04, <italic>P</italic> &lt; 0.005], with ASD [<italic>t</italic>(36) = 2.51, <italic>P</italic> &lt; 0.05] and Sib LCLs [<italic>t</italic>(36) = 3.74, <italic>P</italic> &lt; 0.001] demonstrating significantly higher <italic>UCP2</italic> expression compared to Con LCLs.</p>
</caption>
<graphic xlink:href="fasebj201601004Rf5"></graphic>
</fig>
</sec>
</sec>
<sec id="s14" sec-type="discussion">
<title>DISCUSSION</title>
<p>To our knowledge, this report is the first to compare mitochondrial respiration between LCLs from children with ASD and their Sibs. We report that mitochondrial parameters related to ATP production (ATP-linked respiration and maximal respiratory and reserve capacity) differ significantly between ASD and Sib LCLs, with ASD LCLs exhibiting significantly greater mitochondrial respiration compared to Sib LCLs. Furthermore, ASD mitochondria are more sensitive to an acute increase in ROS than Sibs, exhibiting a greater loss in reserve capacity upon DMNQ exposure. These data suggest that mitochondrial overactivity and hypersensitivity to acute oxidative stress is specifically associated with ASD and support several reports in the literature of mitochondrial overactivity in some children with autism, including greater-than-normal activity of complex I in muscle (<xref ref-type="bibr" rid="B16">16</xref>) and complex IV in muscle (<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B18">18</xref>), skin, (<xref ref-type="bibr" rid="B5">5</xref>) and brain (<xref ref-type="bibr" rid="B19">19</xref>). ASD LCLs also exhibited greater glycolysis and glycolytic capacity compared to Sibs. Glycolysis may be up-regulated in the ASD group as a compensatory mechanism to supply pyruvate to the hyperactive electron transport chain or to simply fill an increased ATP demand.</p>
<p>We examined the role of oxidative stress and redox abnormalities in mitochondrial overactivity by examining intracellular glutathione content and <italic>UCP2</italic> expression in LCLs. Both Sib and ASD LCLs exhibit increased proton leak respiration, decreased glutathione-mediated redox potential (GSH/GSSG), and up-regulated <italic>UCP2</italic> expression, which indicates atypical redox metabolism and is consistent with a more oxidized intracellular microenvironment in both ASD and Sib LCLs and with our earlier findings of redox abnormalities in plasma (<xref ref-type="bibr" rid="B10">10</xref>). Thus, it is not abnormal redox homeostasis <italic>per se</italic> that distinguishes ASD from Con LCLs but rather the overall respiratory rate and how ASD LCL mitochondria respond to oxidative stress.</p>
<p>Mitochondrial dynamics including fusion, fission, replication, and mitophagy, and mitochondrial activity (Krebs cycle and oxidative phosphorylation) are regulated by multiple nutrient and stress-sensing signaling pathways so that ATP production by the mitochondria remains balanced with cellular energy demands and fuel availability (<xref ref-type="bibr" rid="B20">20</xref><xref ref-type="bibr" rid="B21"></xref>–<xref ref-type="bibr" rid="B22">22</xref>). Indeed, mitochondria number, size, and even composition of the electron transport chain components vary in different cell types and tissues in accordance with tissue energy demands (<xref ref-type="bibr" rid="B23">23</xref>, <xref ref-type="bibr" rid="B24">24</xref>). Chronic oxidative stress in the ASD LCLs likely adds to the energy demand and over time results in adaptive changes in mitochondrial dynamics/composition to meet the ATP demand. In ASD LCLs with hyperactive mitochondria, the increased homeostatic set point of mitochondrial ATP production results in a decreased ability to respond to further energy demands. The significant up-regulation of <italic>UCP2</italic> expression in Sib LCLs compared to Cons, although not significantly different than ASD, suggests that Sib LCLs may respond more efficiently than ASD LCLs to increased oxidative stress brought on by environmental stressors by compensating for increased mitochondrial ROS production that would likely occur during an environmental insult.</p>
<p>It is of significant interest to associate these findings with severity of core and associated symptoms of ASD. Interestingly, we found a significant association between ADOS SBRI scores and the ATP-linked respiratory response to DMNQ such that higher SBRI was related to higher ATP-linked respiration at baseline and a greater drop in ATP-linked respiration with DMNQ. SBRI was also associated with glycolytic reserve such that more severe SBRI scores were related to higher glycolytic reserve. Because this study is limited by a small sample size, these preliminary findings should be confirmed in a larger cohort of samples, as well as in isolated peripheral blood mononuclear cells from ASD–Sib pairs. The results of this study are consistent with the notion of a novel type of mitochondrial dysfunction characterized by increased respiration and perturbation of redox-sensitive bioenergetic regulatory pathways is specific for ASD and may possibly be related to etiological processes.</p>
</sec>
</body>
<back>
<ack>
<title>ACKNOWLEDGMENTS</title>
<p>The authors thank the individuals who participated in the Autism Genetic Resource Exchange and Coriell Cell Repository. Support for this study was provided the Arkansas Biosciences Institute (Little Rock, AR, USA), the Jane Botsford Johnson Foundation (New York, NY, USA), and Arkansas Children’s Research Institute. The authors declare no conflicts of interest.</p>
</ack>
<glossary>
<def-list list-content="abbreviations" list-type="simple">
<def-item>
<term id="G1">ADOS</term>
<def>
<p>Autism Diagnostic Observation Schedule</p>
</def>
</def-item>
<def-item>
<term id="G2">ASD</term>
<def>
<p>autism spectrum disorder</p>
</def>
</def-item>
<def-item>
<term id="G3">Con</term>
<def>
<p>control</p>
</def>
</def-item>
<def-item>
<term id="G4">DMNQ</term>
<def>
<p>2,3-dimethoxy-1,4-napthoquinone</p>
</def>
</def-item>
<def-item>
<term id="G5">ECAR</term>
<def>
<p>extracellular acidification rate</p>
</def>
</def-item>
<def-item>
<term id="G6">GSH</term>
<def>
<p>reduced glutathione</p>
</def>
</def-item>
<def-item>
<term id="G7">GSSG</term>
<def>
<p>oxidized glutathione</p>
</def>
</def-item>
<def-item>
<term id="G8">
<italic>HPRT1</italic>
</term>
<def>
<p>hypoxanthine phosphoribosyltransferase 1</p>
</def>
</def-item>
<def-item>
<term id="G9">LCL</term>
<def>
<p>lymphoblastoid cell line</p>
</def>
</def-item>
<def-item>
<term id="G10">ROS</term>
<def>
<p>reactive oxygen species</p>
</def>
</def-item>
<def-item>
<term id="G11">SBRI</term>
<def>
<p>Stereotyped Behaviors and Restricted Interests</p>
</def>
</def-item>
<def-item>
<term id="G12">Sib</term>
<def>
<p>sibling</p>
</def>
</def-item>
<def-item>
<term id="G13">UCP2</term>
<def>
<p>uncoupling protein 2</p>
</def>
</def-item>
</def-list>
</glossary>
<sec id="s15">
<title>AUTHOR CONTRIBUTIONS</title>
<p>S. Rose, S. J. James, and R. E. Frye conceptualized and designed the study; S. Rose and R. E. Frye analyzed data; S. Rose, S. Benurri, R. Wynne, and S. Melynk performed research; and S. Rose wrote the paper.</p>
</sec>
<ref-list>
<title>REFERENCES</title>
<ref id="B1">
<label>1</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rossignol</surname><given-names>D. A.</given-names></name>, <name name-style="western"><surname>Frye</surname><given-names>R. E.</given-names></name></person-group> (<year>2012</year>) <article-title>A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures.</article-title>
<source/>Mol. Psychiatry
<volume>17</volume>, <fpage>389</fpage>–<lpage>401</lpage>
<pub-id pub-id-type="pmid">22143005</pub-id></mixed-citation>
</ref>
<ref id="B2">
<label>2</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rossignol</surname><given-names>D. A.</given-names></name>, <name name-style="western"><surname>Frye</surname><given-names>R. E.</given-names></name></person-group> (<year>2012</year>) <article-title>Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis.</article-title>
<source/>Mol. Psychiatry
<volume>17</volume>, <fpage>290</fpage>–<lpage>314</lpage>
<pub-id pub-id-type="pmid">21263444</pub-id></mixed-citation>
</ref>
<ref id="B3">
<label>3</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Frye</surname><given-names>R. E.</given-names></name>, <name name-style="western"><surname>Rossignol</surname><given-names>D. A.</given-names></name></person-group> (<year>2011</year>) <article-title>Mitochondrial dysfunction can connect the diverse medical symptoms associated with autism spectrum disorders.</article-title>
<source/>Pediatr. Res.
<volume>69</volume>, <fpage>41R</fpage>–<lpage>47R</lpage>
</mixed-citation>
</ref>
<ref id="B4">
<label>4</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Frye</surname><given-names>R. E.</given-names></name></person-group> (<year>2012</year>) <article-title>Biomarker of abnormal energy metabolism in children with autism spectrum disorder.</article-title>
<source/>N. Am. J. Med. Sci. (Boston)
<volume>5</volume>, <fpage>141</fpage>–<lpage>147</lpage>
</mixed-citation>
</ref>
<ref id="B5">
<label>5</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Frye</surname><given-names>R. E.</given-names></name>, <name name-style="western"><surname>Melnyk</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Macfabe</surname><given-names>D. F.</given-names></name></person-group> (<year>2013</year>) <article-title>Unique acyl-carnitine profiles are potential biomarkers for acquired mitochondrial disease in autism spectrum disorder.</article-title>
<source/>Transl. Psychiatry
<volume>3</volume>, <fpage>e220</fpage>
<pub-id pub-id-type="pmid">23340503</pub-id></mixed-citation>
</ref>
<ref id="B6">
<label>6</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Giulivi</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Y. F.</given-names></name>, <name name-style="western"><surname>Omanska-Klusek</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Ross-Inta</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Wong</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Hertz-Picciotto</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Tassone</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Pessah</surname><given-names>I. N.</given-names></name></person-group> (<year>2010</year>) <article-title>Mitochondrial dysfunction in autism.</article-title>
<source/>JAMA
<volume>304</volume>, <fpage>2389</fpage>–<lpage>2396</lpage>
<pub-id pub-id-type="pmid">21119085</pub-id></mixed-citation>
</ref>
<ref id="B7">
<label>7</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Napoli</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Wong</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Hertz-Picciotto</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Giulivi</surname><given-names>C.</given-names></name></person-group> (<year>2014</year>) <article-title>Deficits in bioenergetics and impaired immune response in granulocytes from children with autism.</article-title>
<source/>Pediatrics
<volume>133</volume>, <fpage>e1405</fpage>–<lpage>e1410</lpage>
<pub-id pub-id-type="pmid">24753527</pub-id></mixed-citation>
</ref>
<ref id="B8">
<label>8</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rose</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Frye</surname><given-names>R. E.</given-names></name>, <name name-style="western"><surname>Slattery</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Wynne</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Tippett</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Melnyk</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>James</surname><given-names>S. J.</given-names></name></person-group> (<year>2014</year>) <article-title>Oxidative stress induces mitochondrial dysfunction in a subset of autistic lymphoblastoid cell lines.</article-title>
<source/>Transl. Psychiatry
<volume>4</volume>, <fpage>e377</fpage>
<pub-id pub-id-type="pmid">24690598</pub-id></mixed-citation>
</ref>
<ref id="B9">
<label>9</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rose</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Frye</surname><given-names>R. E.</given-names></name>, <name name-style="western"><surname>Slattery</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Wynne</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Tippett</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Pavliv</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Melnyk</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>James</surname><given-names>S. J.</given-names></name></person-group> (<year>2014</year>) <article-title>Oxidative stress induces mitochondrial dysfunction in a subset of autism lymphoblastoid cell lines in a well-matched case control cohort.</article-title>
<source/>PLoS One
<volume>9</volume>, <fpage>e85436</fpage>
<pub-id pub-id-type="pmid">24416410</pub-id></mixed-citation>
</ref>
<ref id="B10">
<label>10</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Melnyk</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Fuchs</surname><given-names>G. J.</given-names></name>, <name name-style="western"><surname>Schulz</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Lopez</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Kahler</surname><given-names>S. G.</given-names></name>, <name name-style="western"><surname>Fussell</surname><given-names>J. J.</given-names></name>, <name name-style="western"><surname>Bellando</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Pavliv</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Rose</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Seidel</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Gaylor</surname><given-names>D. W.</given-names></name>, <name name-style="western"><surname>James</surname><given-names>S. J.</given-names></name></person-group> (<year>2012</year>) <article-title>Metabolic imbalance associated with methylation dysregulation and oxidative damage in children with autism.</article-title>
<source/>J. Autism Dev. Disord.
<volume>42</volume>, <fpage>367</fpage>–<lpage>377</lpage>
<pub-id pub-id-type="pmid">21519954</pub-id></mixed-citation>
</ref>
<ref id="B11">
<label>11</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dranka</surname><given-names>B. P.</given-names></name>, <name name-style="western"><surname>Hill</surname><given-names>B. G.</given-names></name>, <name name-style="western"><surname>Darley-Usmar</surname><given-names>V. M.</given-names></name></person-group> (<year>2010</year>) <article-title>Mitochondrial reserve capacity in endothelial cells: the impact of nitric oxide and reactive oxygen species.</article-title>
<source/>Free Radic. Biol. Med.
<volume>48</volume>, <fpage>905</fpage>–<lpage>914</lpage>
<pub-id pub-id-type="pmid">20093177</pub-id></mixed-citation>
</ref>
<ref id="B12">
<label>12</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>James</surname><given-names>S. J.</given-names></name>, <name name-style="western"><surname>Rose</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Melnyk</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Jernigan</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Blossom</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Pavliv</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Gaylor</surname><given-names>D. W.</given-names></name></person-group> (<year>2009</year>) <article-title>Cellular and mitochondrial glutathione redox imbalance in lymphoblastoid cells derived from children with autism.</article-title>
<source/>FASEB J.
<volume>23</volume>, <fpage>2374</fpage>–<lpage>2383</lpage>
<pub-id pub-id-type="pmid">19307255</pub-id></mixed-citation>
</ref>
<ref id="B13">
<label>13</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Azzu</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Jastroch</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Divakaruni</surname><given-names>A. S.</given-names></name>, <name name-style="western"><surname>Brand</surname><given-names>M. D.</given-names></name></person-group> (<year>2010</year>) <article-title>The regulation and turnover of mitochondrial uncoupling proteins.</article-title>
<source/>Biochim. Biophys. Acta
<volume>1797</volume>, <fpage>785</fpage>–<lpage>791</lpage>
<pub-id pub-id-type="pmid">20211596</pub-id></mixed-citation>
</ref>
<ref id="B14">
<label>14</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>L. X.</given-names></name>, <name name-style="western"><surname>Skorpen</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Egeberg</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Jørgensen</surname><given-names>I. H.</given-names></name>, <name name-style="western"><surname>Grill</surname><given-names>V.</given-names></name></person-group> (<year>2001</year>) <article-title>Uncoupling protein-2 participates in cellular defense against oxidative stress in clonal beta-cells.</article-title>
<source/>Biochem. Biophys. Res. Commun.
<volume>282</volume>, <fpage>273</fpage>–<lpage>277</lpage>
<pub-id pub-id-type="pmid">11264003</pub-id></mixed-citation>
</ref>
<ref id="B15">
<label>15</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Giardina</surname><given-names>T. M.</given-names></name>, <name name-style="western"><surname>Steer</surname><given-names>J. H.</given-names></name>, <name name-style="western"><surname>Lo</surname><given-names>S. Z.</given-names></name>, <name name-style="western"><surname>Joyce</surname><given-names>D. A.</given-names></name></person-group> (<year>2008</year>) <article-title>Uncoupling protein-2 accumulates rapidly in the inner mitochondrial membrane during mitochondrial reactive oxygen stress in macrophages.</article-title>
<source/>Biochim. Biophys. Acta
<volume>1777</volume>, <fpage>118</fpage>–<lpage>129</lpage>
<pub-id pub-id-type="pmid">18082129</pub-id></mixed-citation>
</ref>
<ref id="B16">
<label>16</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Graf</surname><given-names>W. D.</given-names></name>, <name name-style="western"><surname>Marin-Garcia</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Gao</surname><given-names>H. G.</given-names></name>, <name name-style="western"><surname>Pizzo</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Naviaux</surname><given-names>R. K.</given-names></name>, <name name-style="western"><surname>Markusic</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Barshop</surname><given-names>B. A.</given-names></name>, <name name-style="western"><surname>Courchesne</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Haas</surname><given-names>R. H.</given-names></name></person-group> (<year>2000</year>) <article-title>Autism associated with the mitochondrial DNA G8363A transfer RNA(Lys) mutation.</article-title>
<source/>J. Child Neurol.
<volume>15</volume>, <fpage>357</fpage>–<lpage>361</lpage>
<pub-id pub-id-type="pmid">10868777</pub-id></mixed-citation>
</ref>
<ref id="B17">
<label>17</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Frye</surname><given-names>R. E.</given-names></name>, <name name-style="western"><surname>Naviaux</surname><given-names>R. K.</given-names></name></person-group> (<year>2011</year>) <article-title>Autistic disorder with complex IV overactivity: a new mitochondrial syndrome.</article-title>
<source/>J. Pediatr. Neurol.
<volume>9</volume>, <fpage>427</fpage>–<lpage>434</lpage></mixed-citation>
</ref>
<ref id="B18">
<label>18</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Frye</surname><given-names>R. E.</given-names></name></person-group> (<year>2012</year>) <article-title>Novel cytochrome <italic>b</italic> gene mutations causing mitochondrial disease in autism.</article-title>
<source/>J. Pediatr. Neurol.
<volume>10</volume>, <fpage>35</fpage>–<lpage>40</lpage></mixed-citation>
</ref>
<ref id="B19">
<label>19</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Palmieri</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Papaleo</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Porcelli</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Scarcia</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Gaita</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Sacco</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Hager</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Rousseau</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Curatolo</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Manzi</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Militerni</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Bravaccio</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Trillo</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Schneider</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Melmed</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Elia</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Lenti</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Saccani</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Pascucci</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Puglisi-Allegra</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Reichelt</surname><given-names>K. L.</given-names></name>, <name name-style="western"><surname>Persico</surname><given-names>A. M.</given-names></name></person-group> (<year>2010</year>) <article-title>Altered calcium homeostasis in autism-spectrum disorders: evidence from biochemical and genetic studies of the mitochondrial aspartate/glutamate carrier AGC1.</article-title>
<source/>Mol. Psychiatry
<volume>15</volume>, <fpage>38</fpage>–<lpage>52</lpage>
<pub-id pub-id-type="pmid">18607376</pub-id></mixed-citation>
</ref>
<ref id="B20">
<label>20</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dengjel</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Abeliovich</surname><given-names>H.</given-names></name></person-group> (<year>2016</year>) <article-title>Roles of mitophagy in cellular physiology and development. [E-pub ahead of print]</article-title>
<source/>Cell Tissue Res. doi: 10.1007/s00441-016-2472-0</mixed-citation>
</ref>
<ref id="B21">
<label>21</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Han</surname><given-names>C. Y.</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>T. H.</given-names></name>, <name name-style="western"><surname>Koo</surname><given-names>J. H.</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>S. G.</given-names></name></person-group> (<year>2016</year>) <article-title>Farnesoid X receptor as a regulator of fuel consumption and mitochondrial function.</article-title>
<source/>Arch. Pharm. Res.
<volume>39</volume>, <fpage>1062</fpage>–<lpage>1074</lpage>
<pub-id pub-id-type="pmid">27515052</pub-id></mixed-citation>
</ref>
<ref id="B22">
<label>22</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lindsley</surname><given-names>J. E.</given-names></name>, <name name-style="western"><surname>Rutter</surname><given-names>J.</given-names></name></person-group> (<year>2004</year>) <article-title>Nutrient sensing and metabolic decisions.</article-title>
<source/>Comp. Biochem. Physiol. B Biochem. Mol. Biol.
<volume>139</volume>, <fpage>543</fpage>–<lpage>559</lpage>
<pub-id pub-id-type="pmid">15581787</pub-id></mixed-citation>
</ref>
<ref id="B23">
<label>23</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Puigserver</surname><given-names>P.</given-names></name></person-group> (<year>2005</year>) <article-title>Tissue-specific regulation of metabolic pathways through the transcriptional coactivator PGC1-alpha.</article-title>
<source/>Int. J. Obes.
<volume>29</volume>(<issue>Suppl 1</issue>), <fpage>S5</fpage>–<lpage>S9</lpage>
</mixed-citation>
</ref>
<ref id="B24">
<label>24</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kramer</surname><given-names>P. A.</given-names></name>, <name name-style="western"><surname>Ravi</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Chacko</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Johnson</surname><given-names>M. S.</given-names></name>, <name name-style="western"><surname>Darley-Usmar</surname><given-names>V. M.</given-names></name></person-group> (<year>2014</year>) <article-title>A review of the mitochondrial and glycolytic metabolism in human platelets and leukocytes: implications for their use as bioenergetic biomarkers.</article-title>
<source/>Redox Biol.
<volume>2</volume>, <fpage>206</fpage>–<lpage>210</lpage>
<pub-id pub-id-type="pmid">24494194</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>